ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $1.15 billion. The enterprise value is $877.24 million.

Market Cap	1.15B
Enterprise Value	877.24M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ORIC has 97.39 million shares outstanding. The number of shares has increased by 20.06% in one year.

Current Share Class	97.39M
Shares Outstanding	97.39M
Shares Change (YoY)	+20.06%
Shares Change (QoQ)	+26.66%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	76.08%
Float	63.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.84
P/TBV Ratio	2.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.65, with a Debt / Equity ratio of 0.02.

Current Ratio	14.65
Quick Ratio	14.23
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -39.73% and return on invested capital (ROIC) is -26.50%.

Return on Equity (ROE)	-39.73%
Return on Assets (ROA)	-25.23%
Return on Invested Capital (ROIC)	-26.50%
Return on Capital Employed (ROCE)	-36.01%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.86% in the last 52 weeks. The beta is 1.31, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	+18.86%
50-Day Moving Average	12.37
200-Day Moving Average	9.31
Relative Strength Index (RSI)	45.75
Average Volume (20 Days)	1,178,389

Short Selling Information

The latest short interest is 15.49 million, so 15.91% of the outstanding shares have been sold short.

Short Interest	15.49M
Short Previous Month	13.02M
Short % of Shares Out	15.91%
Short % of Float	24.30%
Short Ratio (days to cover)	13.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-148.02M
Pretax Income	-135.27M
Net Income	-135.27M
EBITDA	-146.82M
EBIT	-148.02M
Earnings Per Share (EPS)	-$1.70

Balance Sheet

The company has $287.14 million in cash and $7.40 million in debt, giving a net cash position of $279.75 million or $2.87 per share.

Cash & Cash Equivalents	287.14M
Total Debt	7.40M
Net Cash	279.75M
Net Cash Per Share	$2.87
Equity (Book Value)	406.92M
Book Value Per Share	4.18
Working Capital	275.42M

Cash Flow

In the last 12 months, operating cash flow was -$116.54 million and capital expenditures -$704,000, giving a free cash flow of -$117.25 million.

Operating Cash Flow	-116.54M
Capital Expenditures	-704,000
Free Cash Flow	-117.25M
FCF Per Share	-$1.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.06%
Shareholder Yield	-20.06%
Earnings Yield	-11.69%
FCF Yield	-10.13%

Analyst Forecast

The average price target for ORIC is $18.78, which is 58.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.78
Price Target Difference	58.48%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2